Diabetes drug may lower colorectal cancer risk: Study
New York, Dec 8 (IANS) A class of medications used to treat Type 2 diabetes may also reduce the risk of colorectal cancer (CRC), according to a study.Glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, are medications to treat type 2…
Read More...
Read More...